20107 results for «»
20107 results
Other peripheral interventions
21 Apr 2021
NSTEMI
21 Apr 2021
Tricuspid / Pulmonary valve
21 Apr 2021
Stents and scaffolds
21 Apr 2021
Next-generation TAVR device will enable lifetime management of aortic stenosis patients
18 May 2021 – From EuroPCR 2021
Watch this session presented by Michael Reardon in order to learn more about supra-annular leaflet functioning in a balloon expandable TAVR device that enables commissural alignment, about 3D single-piece aortic valve design and how it contributes to improved TAVR durability, about the ADAPT tissue science and its proven resistance...
EuroPCR 2021 Experts interviews
Efficient TAVI in the context of expanding indications?
18 May 2021 – From EuroPCR 2021
Watch this session presented by Lars Sondergaard and Didier Tchetche in order to review latest data from the Evolut low-risk trial and the OptimizePro study, to learn more about latest TAVI patient pathway efficiency and economics evidence, and to discover how to translate these insights locally and enable you...
The power of Big Data: can a network meta-analysis reveal the true performance of a DES?
18 May 2021 – From EuroPCR 2021
Watch this session presented by Tullio Palmerini in order to learn about the recently published Network Meta-Analysis on TLF with current DES, to review the role of ultrathin DES in optimising clinical outcomes, and to assess the impact of the results on your daily practice.
Salem Assiri
We CARE: a joint initiative by PCR and Stent – Save a Life!
07 May 2021
Paris, France. Since the start of the COVID-19 pandemic, patients have been consistently deprived of timely cardiovascular treatment. This is due in part to measures taken in response to the sanitary crisis, but it is also due to patients' own unwillingness to seek medical help, even...
Novel Supreme DES with early synchronized antiproliferative drug delivery to inhibit smooth muscle cell proliferation after DES implantation in coronary artery disease: results of the PIONEER III randomized clinical trial
06 May 2021
The PIONEER III trial aims to assess the effectiveness and safety of the biodegradable-polymer sirolimus-eluting Supreme stent compared to durable-polymer everolimus-eluting stent (Xience or Promus), completely releasing the drug by 120 days.
Reviewer
Stefano Garzon
São Paulo, Brazil
José Mariani
Sao Paulo, Brazil
Guy Prado
Sao Paulo, Brazil
Unusual causes of stent failure
28 Apr 2021 – From EuroPCR 2021
Find out more about very late in-scaffold restenosis, consider a shocking treatment for stent underexpansion due to neoatherosclerosis, appreciate coronary intravascular lithotripsy to treat an under-expanded stent, and much more in this session!
HIGHLIFE transseptal mitral valve replacement (TSMVR): clinical study update
18 May 2021 – From EuroPCR 2021
Watch this session presented by Didier Tchetche in order to learn about the HighLife transseptal mitral valve replacement study status, to understand the complex patient population treated and first outcomes, and to be familiar with the current technology and future enhancements.
Impact of anesthesia strategy and valve type on clinical outcomes after transcatheter aortic valve replacement
07 May 2021
The current analysis aimed to compare the safety and efficacy of the Edwards Sapien S3 and Medtronic Corevalve. Furthermore, conscious sedation (CS) and local anaesthesia have been reported to reduce adverse events compared to general anaesthesia (GA) in several observational studies, with a lack of randomised...
Reviewer
Pierre Douette
Liege, Belgium
Hayley Moore
London, United Kingdom
Farhad R. Nezami
Boston, United States of America
